Related Experiment Video

Updated: May 15, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension

Konstantinos Tziomalos1, Vassilios G Athyros, Dimitri P Mikhailidis

  • 1First Propedeutic Department of Internal Medicine, AHEPA Hospital, 1 Stilponos Kyriakidi street, 546 36 Thessaloniki, Greece. ktziomalos@yahoo.com

Current Pharmaceutical Design
|January 5, 2013
PubMed

Insights

Chlorthalidone may be a more effective diuretic than hydrochlorothiazide (HCTZ) for lowering blood pressure and reducing cardiovascular risk. Current guidelines do not consistently recommend one over the other.

Area of Science:

  • Pharmacology
  • Cardiology
  • Nephrology

Background:

  • Hydrochlorothiazide (HCTZ) and chlorthalidone are commonly prescribed diuretics for hypertension.
  • These agents are often considered interchangeable in clinical practice.
  • However, emerging evidence suggests potential differences in efficacy and metabolic effects.

Purpose of the Study:

  • To compare the blood pressure-lowering efficacy of HCTZ and chlorthalidone.
  • To evaluate their differential effects on cardiovascular risk reduction.
  • To assess their impact on metabolic parameters like lipids, potassium, uric acid, and glucose.

Main Methods:

  • Review of randomized controlled trials (RCTs) comparing antihypertensive agents.
  • Analysis of retrospective data, including the Multiple Risk Factor Intervention Trial (MRFIT).
  • Comparative assessment of efficacy and safety profiles.

Main Results:

  • Chlorthalidone demonstrated comparable or superior efficacy in cardiovascular risk reduction compared to other antihypertensives in RCTs.
  • HCTZ treatment yielded conflicting results regarding cardiovascular risk reduction.
  • Retrospective data suggest chlorthalidone may offer greater cardiovascular morbidity reduction than HCTZ.

Conclusions:

  • Chlorthalidone and HCTZ exhibit distinct effects on blood pressure, metabolic profiles, and cardiovascular outcomes.
  • Chlorthalidone appears to be more effective in reducing cardiovascular risk than HCTZ.
  • Further research is needed to establish definitive guidelines for choosing between these diuretics.

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...